Outcome of primary antiphospholipid syndrome in childhood

被引:44
作者
Gattorno, M
Falcini, F
Ravelli, A
Zulian, F
Buoncompagni, A
Martini, G
Resti, M
Picco, P
Martini, A
机构
[1] Univ Genoa, Dipartimento Pediat, Ist Giannina Gaslini, I-16147 Genoa, Italy
[2] Univ Florence, Dipartimento Pediat, Osped Meyer, Florence, Italy
[3] Univ Padua, Dipartimento Pediat, I-35128 Padua, Italy
关键词
antiphospholipid antibodies; childhood; outcome; primary antiphospholipid syndrome;
D O I
10.1191/0961203303lu411oa
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this paper is to investigate the long-term outcome of primary antiphospholipid syndrome (APS) in the paediatric age. The features of unselected patients with primary APS who had disease onset before the age of 16 years were retrospectively analysed in three Italian referral centres. Clinical and laboratory manifestations were assessed to establish whether, at the end of follow-up, the final diagnosis was still primary APS or whether they had developed definite SLE or lupus-like syndrome. Fourteen patients, nine boys and five girls, who had the presenting clinical manifestation of APS between three and 13 years of age (median nine years) and were followed for two to 16 years (median six years). Six patients presented with deep vein thrombosis, five with cerebral stroke, two with peripheral artery occlusion and one with myocardial infarction. During follow-up, four patients had one or more recurrences of vascular thrombosis. At last observation, 10 patients could still be classified as having primary APS, two had developed SLE, one lupus-like syndrome and one Hodgkin's lymphoma. In conclusion; our analysis suggests that some children who present with the features of primary APS may progress to develop SLE or lupus-like syndrome.
引用
收藏
页码:449 / 453
页数:5
相关论文
共 22 条
[1]   ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ANDREWS, PA ;
FRAMPTON, G ;
CAMERON, JS .
LANCET, 1993, 342 (8877) :988-989
[2]  
ANGELINI L, 1994, PEDIATRICS, V94, P500
[3]   THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - MAJOR CLINICAL AND SEROLOGICAL FEATURES [J].
ASHERSON, RA ;
KHAMASHTA, MA ;
ORDIROS, J ;
DERKSEN, RHWM ;
MACHIN, SJ ;
BARQUINERO, J ;
OUTT, HH ;
HARRIS, EN ;
VILARDELLTORRES, M ;
HUGHES, GRV .
MEDICINE, 1989, 68 (06) :366-374
[4]  
ASHERSON RA, 1993, J RHEUMATOL, V20, P1801
[5]  
BERMAN L, 1993, J RHEUMATOL, V20, P1802
[6]   THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - STRIKING ASSOCIATION WITH THE PRESENCE OF CIRCULATING LUPUS ANTICOAGULANT [J].
BOEY, ML ;
COLACO, CB ;
GHARAVI, AE ;
ELKON, KB ;
LOIZOU, S ;
HUGHES, GRV .
BMJ-BRITISH MEDICAL JOURNAL, 1983, 287 (6398) :1021-1023
[7]  
BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
[8]   Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients [J].
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Shoenfeld, Y ;
Camps, MT ;
Jacobsen, S ;
Lakos, G ;
Tincani, A ;
Kontopoulou-Griva, I ;
Galeazzi, M ;
Meroni, PL ;
Derksen, RHWM ;
de Groot, PG ;
Gromnica-Ihle, E ;
Baleva, M ;
Mosca, M ;
Bombardieri, S ;
Houssiau, F ;
Gris, JC ;
Quéré, I ;
Hachulla, E ;
Vasconcelos, C ;
Roch, B ;
Fernández-Nebro, A ;
Boffa, MC ;
Hughes, GRV ;
Ingelmo, M .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1019-1027
[9]  
FALCINI F, 1991, J RHEUMATOL, V18, P1085
[10]  
GATTORNO M, 1995, BRIT J RHEUMATOL, V34, P873